NCT04551521 2025-01-08CRAFT: The NCT-PMO-1602 Phase II TrialGerman Cancer Research CenterPhase 2 Completed72 enrolled
NCT03853707 2024-02-20Ipatasertib in Combination With Carboplatin, Carboplatin/Paclitaxel, or Capecitabine/Atezolizumab in Treating Patients With Metastatic Triple Negative Breast CancerCity of Hope Medical CenterPhase 1/2 Completed28 enrolled 12 charts